drugset / Trial / NCT05795491

Blue Light Emitting Diode Therapy on Vulvovaginal Candidiasis

NCT05795491

Completed 60 enrolled Cairo University
RandomizedParallel-groupSingle-blindTreatment

Summary

With the knowledge that VVC is an infectious disease of the genitourinary tract that is common in women of reproductive age, and because of the shortage of non-drug therapies for this condition, this study will aim to evaluate the effect of ultraviolet A/blue LED with a wavelength of 401 ± 5 nm in patients with a clinical manifestation of candidiasis and its ability to prevent recurrence.

Timeline

Start
2023-04-01
Primary completion
2023-05-01
Completion
2023-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluconazole Small molecule 100 ml Intravenous